scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.FERTNSTERT.2010.09.023 |
P698 | PubMed publication ID | 20979997 |
P50 | author | Paul Devroey | Q7150251 |
Herman Tournaye | Q37835161 | ||
P2093 | author name string | Willem Verpoest | |
Evangelos G Papanikolaou | |||
Basil Tarlatzis | |||
Human Fatemi | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1174-1177 | |
P577 | publication date | 2010-10-27 | |
P1433 | published in | Fertility and Sterility | Q15724525 |
P1476 | title | A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study | |
P478 | volume | 95 |
Q38829575 | An update on the prevention of ovarian hyperstimulation syndrome |
Q38266109 | British Fertility Society Policy and Practice Committee: prevention of ovarian hyperstimulation syndrome |
Q41545744 | Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trial |
Q35471131 | Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study |
Q94572540 | ESHRE guideline: ovarian stimulation for IVF/ICSI† |
Q33770533 | GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis |
Q26800033 | GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis |
Q28077044 | GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article |
Q38222516 | GnRH agonist triggers and their use in assisted reproductive technology: the past, the present and the future |
Q34975528 | Gonadotrophins: The future |
Q24193015 | Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology |
Q33799681 | Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial |
Q24186532 | Luteal phase support for assisted reproduction cycles |
Q40278645 | Luteal-phase ovarian stimulation vs conventional ovarian stimulation in patients with normal ovarian reserve treated for IVF: a large retrospective cohort study |
Q41645905 | Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience |
Q34163177 | Morphological changes of gonadotropin-releasing hormone neurons in the rat preoptic area across puberty |
Q35591046 | New algorithm for OHSS prevention |
Q55279761 | Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. |
Q41155931 | Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome |
Q34009789 | Pharmaceutical options for triggering of final oocyte maturation in ART |
Q34458877 | The Luteal Phase after GnRHa Trigger-Understanding An Enigma |
Q48653020 | The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation |
Search more.